Susquehanna International Group, LLP Astrazeneca PLC Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Astrazeneca PLC stock. As of the latest transaction made, Susquehanna International Group, LLP holds 106,659 shares of AZN stock, worth $7.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

106,659

Previous 168,663 36.76%

Holding current value

$7.76 Million

Previous $13.2 Million 36.83%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $4.75 Million - $5.43 Million	-62,004 Reduced 36.76%	106,659 $8.31 Million
Q2 2024 Aug 15, 2024	BUY	$66.81 - $80.83 $7.31 Million - $8.84 Million	109,390 Added 184.55%	168,663 $13.2 Million
Q1 2024 May 07, 2024	SELL	$61.03 - $69.57 $3.11 Million - $3.54 Million	-50,953 Reduced 46.23%	59,273 $4.02 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $4.53 Million - $5.07 Million	73,202 Added 197.71%	110,226 $7.42 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $49.1 Million - $54.2 Million	-756,484 Reduced 95.33%	37,024 $2.51 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $41.3 Million - $44.8 Million	591,217 Added 292.26%	793,508 $56.8 Million
Q1 2023 May 16, 2023	BUY	$63.15 - $71.6 $5.65 Million - $6.41 Million	89,533 Added 79.4%	202,291 $14 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $2.25 Million - $2.92 Million	-41,441 Reduced 26.88%	112,758 $7.64 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $13.5 Million - $34.6 Million	-254,737 Reduced 62.29%	154,199 $8.46 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $2.95 Million - $3.54 Million	49,717 Added 13.84%	408,936 $27 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $27.4 Million - $33 Million	-491,157 Reduced 57.76%	359,219 $23.8 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $110 Million - $130 Million	-2,030,621 Reduced 70.48%	850,376 $49.5 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $134 Million - $147 Million	2,413,919 Added 516.81%	2,880,997 $173 Million
Q2 2021 Aug 11, 2021	SELL	$48.42 - $60.18 $33.1 Million - $41.2 Million	-684,083 Reduced 59.43%	467,078 $28 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $75.5 Million - $87.2 Million	-1,601,822 Reduced 58.18%	1,151,161 $57.2 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $24.1 Million - $28.8 Million	496,426 Added 22.0%	2,752,983 $138 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $47.8 Million - $55.1 Million	901,162 Added 66.49%	2,256,557 $124 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $51.6 Million - $66.2 Million	1,197,688 Added 759.44%	1,355,395 $71.7 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $1.92 Million - $2.61 Million	50,753 Added 47.45%	157,707 $7.04 Million
Q2 2019 Aug 16, 2019	BUY	$37.28 - $41.68 $51,781 - $57,893	1,389 Added 1.32%	106,954 $4.42 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $3.67 Million - $4.11 Million	98,506 Added 1395.47%	105,565 $4.36 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $52,099 - $63,153	-1,468 Reduced 17.22%	7,059 $285,000
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $2.68 Million - $3.01 Million	-72,590 Reduced 89.49%	8,527 $324,000
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $1.66 Million - $1.9 Million	-47,863 Reduced 37.11%	81,117 $3.21 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $5.84 Million - $6.27 Million	-169,124 Reduced 56.73%	128,980 $4.53 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $8.59 Million - $9.54 Million	260,504 Added 692.83%	298,104 $10.4 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $692,341 - $750,378	21,575 Added 134.63%	37,600 $1.31 Million
Q3 2017 Nov 20, 2017	BUY	$28.96 - $34.0 $464,084 - $544,850	16,025	16,025 $543,000

Others Institutions Holding AZN

# of Institutions

1,344

Shares Held

478M

Call Options Held

5.39M

Put Options Held

3.79M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $225B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Astrazeneca PLC Transaction History